NIH research on Trump Derangement Syndrome within existing programs

(a) In general The Director of the National Institutes of Health, through the existing programs and authorities of the National Institute of Mental Health and other relevant institutes and centers, shall conduct or support research to advance the understanding of Trump Derangement Syndrome, including its origins, manifestations, and long-term effects. (b) Research objectives The research conducted under subsection (a) shall include— (1) efforts to identify the initial emergence or earliest documented cases (commonly referred to as patient zero or index cases) of TDS, including historical and social analyses to trace the onset of TDS; (2) investigation of the long-term psychological, social, or behavioral impacts of TDS on affected individuals, communities, or public discourse; (3) analysis of contributing factors, such as media exposure, political polarization, or social dynamics, to the development or spread of TDS; and (4) exploration of potential interventions, coping mechanisms, or strategies to mitigate adverse effects of TDS, as applicable. (c) Collaboration The Director shall collaborate with the heads of other Federal agencies, academic institutions, and relevant organizations, as appropriate, to achieve the objectives described in subsection (b). (d) Annual report to Congress Not later than 2 years after the date of enactment of this Act, and annually thereafter, the Director shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on— (1) the progress of research conducted under this section; (2) any findings related to the initial emergence or long-term effects of TDS; and (3) recommendations for further research or public health actions.